CRM
59
4
BLK
46
2
UNP
38
2
LOW
39
5
D
53
5
PH
57
4
UNH
45
4
YUM
33
-2
ALLE
19
3
MLM
32
5
LLY
37
4
FITB
36
-3
EIX
47
-11
NDAQ
50
4
BDX
65
2
BSX
73
4
VRSK
56
16
WHR
62
-2
VZ
27
3
ISRG
67
5
CRM
59
4
BLK
46
2
UNP
38
2
LOW
39
5
D
53
5
PH
57
4
UNH
45
4
YUM
33
-2
ALLE
19
3
MLM
32
5
LLY
37
4
FITB
36
-3
EIX
47
-11
NDAQ
50
4
BDX
65
2
BSX
73
4
VRSK
56
16
WHR
62
-2
VZ
27
3
ISRG
67
5
Financhill
Back

DFA Dimensional US Core Equity 2 ETF Vs. Janux Therapeutics Industry Stock Comparison

Sell
45

DFAC
DFA Dimensional US Core Equity 2 ETF

Last Price:
$34.86
Seasonality Move:
6.9%
Sell
23

JANX
Janux Therapeutics

Last Price:
$50.53
Seasonality Move:
80.32%
Sell
45
DFA Dimensional US Core Equity 2 ETF (DFAC) is a Sell

Is DFA Dimensional US Core Equity 2 ETF a Buy, Sell or Hold?

  • The current DFA Dimensional US Core Equity 2 ETF [DFAC] share price is $34.85. The Score for DFAC is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • DFAC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Janux Therapeutics (JANX) is a Sell

Is Janux Therapeutics a Buy, Sell or Hold?

  • The current Janux Therapeutics [JANX] share price is $50.82. The Score for JANX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • JANX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DFAC Stock Price Chart

What is DFA Dimensional US Core Equity 2 ETF's stock price today?

  • The DFA Dimensional US Core Equity 2 ETF share price today is $34.85
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DFAC is experiencing buying pressure, which is a positive indicator for future bullish movement.

JANX Stock Price Chart

What is Janux Therapeutics's stock price today?

  • The Janux Therapeutics share price today is $50.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.

DFAC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.23 Sell
Relative Strength Index (14 RSI): 43.36 Sell
Chaikin Money Flow: 1598017 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.71 - 36.15) Sell
Bollinger Bands (100): (33.6 - 35.72) Buy

JANX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 41.88 Sell
Chaikin Money Flow: -1994706 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.74 - 62.68) Sell
Bollinger Bands (100): (44.76 - 56.7) Buy

DFAC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.81 Buy
20-day SMA: 35.18 Sell
50-day SMA: 35.45 Sell
200-day SMA: 33.28 Buy
8-day EMA: 34.89 Sell
20-day EMA: 35.13 Sell
50-day EMA: 35.17 Sell
200-day EMA: 33.32 Buy

JANX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.68 Sell
20-day SMA: 56.78 Sell
50-day SMA: 54.64 Sell
200-day SMA: 47.7 Buy
8-day EMA: 54.12 Sell
20-day EMA: 55.17 Sell
50-day EMA: 54.12 Sell
200-day EMA: 45.19 Buy

DFA Dimensional US Core Equity 2 ETF Earnings Growth & DFAC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Janux Therapeutics Earnings Growth & JANX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.92 per share, and a decrease next year of $0.75 per share.

DFA Dimensional US Core Equity 2 ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Janux Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):